from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3604c/-

LFCtreatmentdescriptionclass of inhibitor

0.752

Amikacinug/mL Amikacintranslation

0.327

Cap5-10ug/mL Capreomycintranslation

0.261

Rox10-50 ug/mL Roxithromycintranslation

0.363

SM2-5 ug/mL Streptomycintranslation

0.380

Tet5-10 ug/mL Tetracyclinetranslation

-0.097

Rif0.2-5ug/mL Rifampicintranscription

-0.471

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.327

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.054

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.278

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.284

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.237

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.074

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.334

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.936

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.901

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.219

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.444

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.400

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.307

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.004

KCN5-20 ug/mL Potassium cyaniderespiration

0.809

NaN30.2-2 mM Sodium aziderespiration

-0.847

Nigericin50 uM Nigericinrespiration

0.253

TRC10-150 ug/mL Triclosanrespiration

-2.050

TRZ10-25 ug/mL Thioridazinerespiration

0.135

Valinomycin0.5-10 uM Valinomycinrespiration

-0.654

ZnSO42 mM ZnSO4respiration

0.022

menadione6-10 ug/mL Menadionerespiration

-0.622

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.385

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.253

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.125

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.810

NRP_1Non-replicating persistence stage 1dosRassociated

0.696

Amp0.2mg/mL AmpicillincellWall

1.046

Cephalexin20-100 ug/mL CephalexincellWall

-0.004

Cerulenin0.32-5 ug/mL CerulenincellWall

0.045

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.314

EMB10-20 ug/mL EthambutolcellWall

0.603

Eta12-40 ug/mL EthionamidecellWall

1.005

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.098

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.465

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.361

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.036

BZA0.12 mg/mL BenzamidearomaticAmides

0.052

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.245

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.378

H2O24 mM hydrogen peroxideDNAdamaging

-0.094

Levo10 ug/mL LevofloxacinDNAdamaging

0.488

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.189

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.564

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.420

UVUV-irradiationDNAdamaging

-0.730

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.700

Antimycin12.5-50 ug/mL Antimycin A?

0.353

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.159

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.441

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.572

PA8240.2-2 ug/mL PA-824?

0.812

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.118

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.254

Verapamil50 uM Verapamil?

-0.397

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.155

methoxatin10-20 ug/mL Methoxatin?